Back
STF Tactical Growth & Income ETF Vs. Cidara Therapeutics Industry Stock Comparison
Sell
41
TUGN
STF Tactical Growth & Income ETF
Last Price:
$25.15
Seasonality Move:
-5.5%
Buy
77
CDTX
Cidara Therapeutics
Last Price:
$62.00
Seasonality Move:
2.01%
Sell
41
STF Tactical Growth & Income ETF (TUGN)
is a Sell
Is STF Tactical Growth & Income ETF a Buy, Sell or Hold?
-
The current STF Tactical Growth & Income ETF [TUGN] share price is $25.11. The Score for TUGN is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
TUGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
77
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy, Sell or Hold?
-
The current Cidara Therapeutics [CDTX] share price is $62.00. The Score for CDTX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TUGN Stock Price Chart
What is STF Tactical Growth & Income ETF's stock price today?
-
The STF Tactical Growth & Income ETF share price today is $25.11Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TUGN is experiencing selling pressure, which indicates risk of future bearish movement.
CDTX Stock Price Chart
What is Cidara Therapeutics's stock price today?
-
The Cidara Therapeutics share price today is $62.00Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing slight selling pressure.
TUGN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.87 | Buy |
Relative Strength Index (14 RSI): | 58.84 | Buy |
Chaikin Money Flow: | -197292 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.67 - 25.05) | Buy |
Bollinger Bands (100): | (21.58 - 24.7) | Buy |
CDTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 17.06 | Buy |
Relative Strength Index (14 RSI): | 66.1 | Buy |
Chaikin Money Flow: | -5264 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (54 - 63.66) | Buy |
Bollinger Bands (100): | (16.68 - 50.42) | Buy |
TUGN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.83 | Buy |
20-day SMA: | 24.9 | Buy |
50-day SMA: | 24.43 | Buy |
200-day SMA: | 23.57 | Buy |
8-day EMA: | 22.92 | Buy |
20-day EMA: | 15.74 | Buy |
50-day EMA: | 8.2 | Buy |
200-day EMA: | 2.37 | Buy |
CDTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 62.27 | Sell |
20-day SMA: | 60.63 | Buy |
50-day SMA: | 46.09 | Buy |
200-day SMA: | 26.83 | Buy |
8-day EMA: | 57.04 | Buy |
20-day EMA: | 39.3 | Buy |
50-day EMA: | 20.5 | Buy |
200-day EMA: | 5.92 | Buy |
STF Tactical Growth & Income ETF Earnings Growth & TUGN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Cidara Therapeutics Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $4.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $16.92 per share, and a decrease next year of $1.83 per share.
STF Tactical Growth & Income ETF Technical Analysis
Jul 29 | Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Cidara Therapeutics Technical Analysis
Jul 29 | Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |